Delivery of siRNA targeting HIF-1α loaded chitosan modified<scp>d</scp>-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin
RSC advances